Skip to main content

Advertisement

SpringerLink
Log in

Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie der pulmonalen Hypertonie bei Patienten mit Autoimmunerkrankungen

  • BEITRAG ZUM SCHWERPUNKTTHEMA
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Galie, N, Seeger, W, Naeije, R, Simonneau, G, Rubin, LJ (2004) Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 43:81S–88S

    Google Scholar 

  2. Fedullo PF, Auger WR, Kerr KM, Rubin LJ (2001) Chronic thromboembolic pulmonary hypertension. N Engl J Med 345:1465–1472

    Article  CAS  PubMed  Google Scholar 

  3. Prasad S, Wilkinson J, Gatzoulis MA (2000) Sildenafil in primary pulmonary hypertension. N Engl J Med 343:1342

    CAS  PubMed  Google Scholar 

  4. Wilkens H, Guth A, Konig J, Forestier N, Cremers B, Hennen B, Bohm M, Sybrecht GW (2001) Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104:1218–1222

    CAS  PubMed  Google Scholar 

  5. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S (2002) Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105:2398–2403

    Google Scholar 

  6. Abrams D, Schulze-Neick I, Magee AG (2000) Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4

    Google Scholar 

  7. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F (2002) Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136:515–522

    CAS  PubMed  Google Scholar 

  8. Sastry BK, Narasimhan C, Reddy NK, Raju BS (2004) Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43:1149–1153

    Article  CAS  PubMed  Google Scholar 

  9. Watanabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran QK, Satoh H, Terada H, Ohashi H, Hayashi H (2002) Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 71:398–402

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinische Forschergruppe III, Nikolaus-Fiebiger-Zentrum für Molekulare Medizin, Glückstraße 6, 91054, Erlangen

    H. Schulze-Koops

Authors
  1. H. Schulze-Koops
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Schulze-Koops.

Additional information

und die Kommission Pharmakotherapie der DGRh

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulze-Koops, H. Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie der pulmonalen Hypertonie bei Patienten mit Autoimmunerkrankungen. Z. Rheumatol. 64, 93–95 (2005). https://doi.org/10.1007/s00393-005-0693-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-005-0693-9

Search

Navigation